ICD-10-CM Billable Code

Z92.26

Personal history of immune checkpoint inhibitor therapy

Clinical Classification Guidelines

Inclusion Terms

  • Personal history of ICI drug therapy

Medical Intelligence & Overview

ICD-10 code Z92.26 pertains to a person's medical history indicating they have previously undergone immune checkpoint inhibitor (ICI) therapy. This type of treatment involves the use of specific drugs designed to enhance the body's immune response against cancer. Recognizing this history is important for healthcare providers to understand past treatments and their potential implications for future health management.

Causes & Symptoms

Clinical Causes: Diagnosis of certain cancers where immune checkpoint inhibitors are a standard treatment, such as melanoma, non-small cell lung cancer, or bladder cancer. Clinical decision to use ICI therapy as part of cancer treatment plan, based on tumor type, genetic markers, and overall health status.

Key Symptoms: History of side effects related to ICI therapy, such as fatigue, rash, or inflammation. Indicators of immune-related adverse events that may have occurred during or after treatment, including thyroid issues, colitis, or pneumonitis. No current symptoms directly caused by the therapy, but informed by previous reactions or ongoing monitoring needs.

Diagnostic & Treatment

Diagnosis Path: The diagnosis of a personal history of ICI therapy is documented through medical records, treatment history, and patient interviews. Healthcare providers confirm prior treatments via records and may perform assessments if related complications or immune-related adverse events are suspected. This history is categorized under ICD-10 code Z92.26 to ensure accurate medical documentation.

Treatment Protocols: Since Z92.26 indicates a historical treatment, ongoing management depends on individual health status and previous responses to ICI therapy. Patients may require regular monitoring for late-onset side effects or immune-related conditions. Treatment considerations include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z92.26 a billable ICD-10 code?
Yes, Z92.26 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z92.26?
Clinical documentation must specify the nature of Personal history of immune checkpoint inhibitor therapy and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

checkpoint immune inhibitor therapy